5 On-The-Money Stock Picks For December From Benzinga's Most Accurate Analysts
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.
Benzinga's Analyst Ratings API is a collection of the highest-quality stock ratings curated by the Benzinga news desk via direct partnerships with major sell-side banks. Benzinga displays overnight ratings changes on a daily basis three hours prior to the U.S. equity market opening. Data specialists at investment dashboard provider Toggle.ai recently uncovered that the analyst insights Benzinga Pro subscribers and Benzinga readers regularly receive can successfully be used as trading indicators to outperform the stock market.
Top Analyst Picks: Fortunately, any Benzinga reader can access the latest analyst ratings on the Analyst Stock Ratings page. One of the ways traders can sort through Benzinga's extensive database of analyst ratings is by analyst accuracy. Here's a look at the most recent stock picks from each of the five most accurate Wall Street analysts, according to Benzinga Analyst Stock Ratings.
- Analyst: Rick Patel
Analyst Firm: Raymond James
Ratings Accuracy: 88%
Latest Rating: Maintained an Outperform Buy rating on NIKE, Inc. (NYSE:NKE) on December 21, 2022, and boosted the price target from $99 to $130. Patel sees around 11% increase in the company’s stock.
- Analyst: Michael Hoffman
Analyst Firm: Stifel
Ratings Accuracy: 86%
Latest Rating: Maintained a Buy rating on Charah Solutions, Inc. (NYSE:CHRA) on December 30, 2022, and raised the price target from $2 to $17. Hoffman predicts around 202% upside in the stock.
- Analyst: Joseph Quatrochi
Analyst Firm: Barclays
Ratings Accuracy: 86%
Latest Rating: Reiterated an Equal-Weight rating for MKS Instruments, Inc. (NASDAQ:MKSI) on December 15, 2022, and raised the price target from $70 to $80. This analyst expects around 6% decline in the company’s stock.
Check This Out: Investor Fear Eases Slightly On Last Trading Day Of 2022
- Analyst: Bill Sutherland
Analyst Firm: Benchmark
Ratings Accuracy: 84%
Latest Rating: Initiated a Buy rating for Nutex Health Inc (NASDAQ:NUTX) on December 23, 2022, with a price target of $3. Sutherland sees the stock gaining more than 57%.
- Analyst: Shneur Gershuni
Analyst Firm: UBS
Ratings Accuracy: 84%
Latest Rating: Maintained a Buy rating on Targa Resources Corp. (NYSE:TRGP) on December 15, 2022, and cut the price target from $107 to $106. Gershuni sees around 44% surge in the stock.